EGLARO S 5MG 100MG TAB (14s)

SEO-friendly product description for EGLARO S 5MG/100MG Tablet (14s):

EGLARO S 5mg/100mg Tablets (14s) combine two powerful ingredients to effectively manage hypertension and cardiovascular risk. This dual-action formula contains empagliflozin 5mg and sitagliptin 100mg, helping control blood sugar levels in type 2 diabetes patients while also offering heart and kidney protection.

Key Features:

• Combination of Empagliflozin 5mg and Sitagliptin 100mg

• Supports blood sugar control in type 2 diabetes

• May reduce the risk of cardiovascular events

• Enhances kidney function protection

• Pack of 14 tablets – convenient weekly supply

Directions for Use:
Take as prescribed by your healthcare provider. Do not exceed the recommended dose.

Disclaimer:
Not suitable for type 1 diabetes or diabetic ketoacidosis. Use under medical supervision, especially in patients with kidney or heart conditions.